Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

PCRX Q4 2016 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

Q4 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$73M

Gross Profit

$49M67.6% margin

Operating Income

-$2M-3.4% margin

Net Income

-$4M-5.4% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$12M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$391M

Total Liabilities

$172M

Stockholders' Equity

$219M

Cash & Equivalents

$36M

← FY 2016 All Quarters Q1 2017 →